Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancer.

MLA

Mahadevan, Krishnan K., et al. “Antigen-Presenting Type-I Conventional Dendritic Cells Facilitate Curative Checkpoint Blockade Immunotherapy in Pancreatic Cancer.” BioRxiv : The Preprint Server for Biology, Mar. 2023. EBSCOhost, https://doi.org/10.1101/2023.03.05.531191.

APA

Mahadevan, K. K., Dyevoich, A. M., Chen, Y., Li, B., Sugimoto, H., Sockwell, A. M., McAndrews, K. M., Wang, H., Shalapour, S., Watowich, S. S., & Kalluri, R. (2023). Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancer. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2023.03.05.531191

Chicago

Mahadevan, Krishnan K, Allison M Dyevoich, Yang Chen, Bingrui Li, Hikaru Sugimoto, Amari M Sockwell, Kathleen M McAndrews, et al. 2023. “Antigen-Presenting Type-I Conventional Dendritic Cells Facilitate Curative Checkpoint Blockade Immunotherapy in Pancreatic Cancer.” BioRxiv : The Preprint Server for Biology, March. doi:10.1101/2023.03.05.531191.